We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene Analysis Identifies People at Risk for Diabetes

By Biotechdaily staff writers
Posted on 05 Aug 2003
Researchers studying the genetic basis for diabetes have identified a group of 187 genes that are expressed differently in patients suffering from type 2 diabetes, and showed that 55 of these genes are expressed in asymptomatic individuals with a family history of the disease.

Investigators at Joslin Diabetes Center (Boston, MA, USA) used DNA microarray techniques to measure the expression of over 7,000 genes in muscle tissue from normal, diabetic, or pre-diabetic (having a family history of diabetes) Mexican-Americans, an ethnic group with a very high risk for diabetes. More...
They found that 187 genes were expressed differently between normals and diabetics, and that 166 genes were expressed differently between normals and pre-diabetics. A group of 55 genes were expressed differently in both groups.


Two of the 55 genes, PCG1-alpha and PCG1-beta, showed reduced expression that lead to the reduced activity of a larger group of genes involved in the metabolism of fats and carbohydrates. Many of the genes in the larger group encode for proteins in the mitochondria and are regulated by the NRF-1 gene. These findings were published in the July 8, 2003, issue of the Proceedings of the National Academy of Sciences.

"Knowing which genes are turned on or off in people before they develop diabetes is a key piece of information needed to solve the puzzle of diabetes, and to identify new ways to treat and prevent this devastating disease,” explained first author Dr. Mary-Elizabeth Patti, director of the genomics laboratory at Joslin Diabetes Center. "If we can identify people at high risk for diabetes and learn to prevent these changes from taking place, we may be able to find better methods for both treatment and prevention of diabetes.”



Related Links:
Joslin Diabetes Center

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Repetitive Pipette
VWR® Stepper Pro
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.